Sateesh Natarajan

Sateesh Natarajan is a seasoned professional in the biopharmaceutical field, currently serving as Senior Vice President of CMC Product Development at Enlaza Therapeutics since March 2023. Previously, Sateesh functioned as a consultant in the biotech sector, providing expertise on biologics platforms and product development from July 2022 to March 2023. Prior roles include Senior Vice President of CMC Product Development at Silverback Therapeutics, where Sateesh was instrumental in the technical development of antibody-drug conjugates, and Vice President of Biologics Product Development at Dr. Reddy's Laboratories, focusing on biosimilar strategies. Sateesh's extensive experience includes key positions at Emergent BioSolutions, Trubion Pharmaceuticals, and Dendreon, demonstrating a strong background in protein science, drug development, and oncology. Sateesh holds a B.Tech in Chemical Engineering from the Indian Institute of Technology, Madras, a Ph.D. in Chemical and Biochemical Engineering from the University of Maryland Baltimore County, and completed post-doctoral work in Immunology and Biophysical Chemistry at The Johns Hopkins University School of Medicine.